Riviere M - Search Results

1

An analysis of extended survival in patients with amyotrophic lateral sclerosis treated with riluzole.

Riviere M, Meininger V, Zeisser P, Munsat T. Riviere M, et al. Arch Neurol. 1998 Apr;55(4):526-8. doi: 10.1001/archneur.55.4.526. Arch Neurol. 1998. PMID: 9561981 Clinical Trial.

2

Economic analysis of Neoral in de novo renal transplant patients in Canada.

Kingma I, Ludwin D, Dandavino R, Wolff JL, Loertscher R, Beauregard-Zollinger L, Bacquet P, Boucher S, Rivière M. Kingma I, et al. Among authors: riviere m. Clin Transplant. 1997 Feb;11(1):42-8. Clin Transplant. 1997. PMID: 9067694 Clinical Trial.

3

Cost-effectiveness of simvastatin in the secondary prevention of coronary artery disease in Canada.

Rivière M, Wang S, Leclerc C, Fitzsimon C, Tretiak R. Rivière M, et al. CMAJ. 1997 Apr 1;156(7):991-7. CMAJ. 1997. PMID: 9099167 Free PMC article. Clinical Trial.

4

Cost of allogeneic and autologous blood transfusion in Canada. Canadian Cost of Transfusion Study Group.

Tretiak R, Laupacis A, Rivière M, McKerracher K, Souêtre E. Tretiak R, et al. Among authors: riviere m. CMAJ. 1996 May 15;154(10):1501-8. CMAJ. 1996. PMID: 8625000 Free PMC article.

5

Economic analysis of Sandimmune Neoral in Canada in stable renal transplant patients.

Keown P, Lawen JG, Landsberg D, Beauregard-Zollinger L, Rivière M, Leclerc C, Hardens M. Keown P, et al. Among authors: riviere m. Transplant Proc. 1995 Apr;27(2):1845-8. Transplant Proc. 1995. PMID: 7725530 No abstract available.

6

Is paclitaxel and cisplatin a cost-effective first-line therapy for advance ovarian carcinoma?

Covens A, Boucher S, Roche K, Macdonald M, Pettitt D, Jolain B, Souetre E, Rivière M. Covens A, et al. Among authors: riviere m. Cancer. 1996 May 15;77(10):2086-91. doi: 10.1002/(SICI)1097-0142(19960515)77:10<2086::AID-CNCR18>3.0.CO;2-R. Cancer. 1996. PMID: 8640674

7

Cost of chickenpox in Canada: part II. Cost of complicated cases and total economic impact. The Immunization Monitoring Program-Active (IMPACT).

Law B, Fitzsimon C, Ford-Jones L, McCormick J, Rivière M. Law B, et al. Among authors: riviere m. Pediatrics. 1999 Jul;104(1 Pt 1):7-14. doi: 10.1542/peds.104.1.7. Pediatrics. 1999. PMID: 10390253

8

Economic benefits of a routine second dose of combined measles, mumps and rubella vaccine in Canada.

Rivière M, Tretiak R, Levinton C, Fitzsimon C, Leclerc C. Rivière M, et al. Can J Infect Dis. 1997 Sep;8(5):257-64. doi: 10.1155/1997/215175. Can J Infect Dis. 1997. PMID: 22346520 Free PMC article.

9

Cost of chickenpox in Canada: part I. Cost of uncomplicated cases.

Law B, Fitzsimon C, Ford-Jones L, MacDonald N, Déry P, Vaudry W, Mills E, Halperin S, Michaliszyn A, Rivière M. Law B, et al. Among authors: riviere m. Pediatrics. 1999 Jul;104(1 Pt 1):1-6. doi: 10.1542/peds.104.1.1. Pediatrics. 1999. PMID: 10390252

10

The revised Canadian Guidelines for the Economic Evaluation of Pharmaceuticals.

Glennie JL, Torrance GW, Baladi JF, Berka C, Hubbard E, Menon D, Otten N, Rivière M. Glennie JL, et al. Among authors: riviere m. Pharmacoeconomics. 1999 May;15(5):459-68. doi: 10.2165/00019053-199915050-00004. Pharmacoeconomics. 1999. PMID: 10537963

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results